Gábor Somlyai

CEO

Gábor Somlyai graduated as a biologist at the University of Szeged in 1982 Between 1982 és
1990 he worked for the Plant Protection Institute, from 1983 to 1986 he had a scholarship from
the Hungarian Academy of Sciences as a postgraduate student for obtaining Ph.D. In 1988 he
defended his thesis in molecular biology. In the same year dr. Somlyai spent 6 months at the
Georg-August University in Göttingen with a DFG scholarship and from the end of 1988 he
held a postdoctoral fellowship at the University of Missouri. Since 1990, dr. Somlyai started
his research, examining the biological importance of naturally occurring deuterium, as a
senior research fellow at the Hungarian Institute of Oncology. In 1993, he established HYD
Ltd. to carry out anticancer research and drug development based on the proprietary
procedure, deuterium depletion, and to start drug registration. Between 1993 and 1997 he
was the scientific director of HYD Ltd., from 1997 he became the CEO of the company. Gábor
Somlyai wrote numerous scientific publications and is a recognized speaker at international
conferences. Gábor Somlyai is the inventor of numerous international patents.